Generalizable Prognostic Models for Patient-Centered Decisions in COVID-19
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 21
- 试验地点
- 2
- 主要终点
- Changes in model calibration (Model 1: need for MV in patients hospitalized with COVID-19)
研究概览
简要总结
Approximately 20% of patients hospitalized with COVID-19 require intensive care and possibly invasive mechanical ventilation (MV). Patient preferences with COVID-19 for MV may be different, because intubation for these patients is often prolonged (for several weeks), is administered in settings characterized by social isolation and is associated with very high average mortality rates. Supporting patients facing this decision requires providing an accurate forecast of their likely outcomes based on their individual characteristics.
The investigators therefore aim to:
- Develop 3 CPMs in each of 2 hospital systems (i.e., 6 distinct models) to predict:
i) the need for MV in patients hospitalized with COVID-19; ii) mortality in patients receiving MV; iii) length of stay in the ICU. 2. Evaluate the geographic and temporal transportability of these models and examine updating approaches.
- To evaluate geographic transportability, the investigators will apply the evaluation and updating framework developed (in the parent PCORI grant) to assess CPM validity and generalizability across the different datasets.
- To evaluate temporal transportability, the investigators will examine both the main effect of calendar time and also examine calendar time as an effect modifier.
- Engage stakeholders to facilitate best use of these CPMs in the care of patients with COVID-19.
详细描述
There has been a proliferation of COVID-19 clinical prediction models (CPMs) reported in the literature across health systems, but the validity and potential generalizability of these models to other settings is unknown. Generally, most hospitals (and systems) do not have a sufficient number of cases (and outcomes) to develop models fit to their local population, and predictor variables are not uniformly and reliably obtained across systems. Therefore, pooling and harmonizing data resources and assessing generalizability across different sites is urgently needed to create tools that may help support decision making across settings. In addition, since best practices are rapidly evolving over time (e.g., proning, minimizing paralytics, lung-protective volumes, remdesivir, dexamethasone or other treatments), updating and recalibrating these CPMs is crucially important.
In the current PCORI Methods project, the investigators developed a CPM evaluation and updating framework including both conventional and novel performance measures. The investigators will use this framework to evaluate COVID-19 prognostic models in the largest cohort of COVID-19 patients examined to date, spanning 2 datasets from very different settings. As the COVID-19 pandemic affects different regions, with subsequent waves expected, identifying the most accurate, robust and generalizable prognostic tools is needed to guide patient-centered decision making across diverse populations and settings.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •COVID-19 patient survivor
- •Family member/caregiver of patient hospitalized for COVID-19
- •Physician with experience caring for COVID-19 patients
- •Other provider (pastoral care, nursing, respiratory therapy) with experience caring for COVID-19 patients
排除标准
- •Not proficient in reading or speaking English
结局指标
主要结局
Changes in model calibration (Model 1: need for MV in patients hospitalized with COVID-19)
时间窗: 30 days from hospitalization
Aim 1 Outcome-Changes in Harrell's E for models predicting the probability of: the need for MV in patients hospitalized with COVID-19.
Changes in model discrimination (Model 1: need for MV in patients hospitalized with COVID-19)
时间窗: 30 days from hospitalization
Aim 1 Outcome: Changes in Area under receiver operating characteristic curve (AUC) \[delta AUC\] for models predicting the probability of: the need for MV in patients hospitalized with COVID-19.
Changes in model discrimination (Model 2: mortality in patients receiving MV)
时间窗: 30 days from hospitalization
Aim 1 Outcome: Changes in Area under receiver operating characteristic curve (AUC) \[delta AUC\] for models predicting the probability of: mortality in patients receiving MV.
Changes in net benefit (Model 3: length of stay in the ICU)
时间窗: 30 days from hospitalization
Aim 1 Outcome-Changes in Net Benefit for models predicting the probability of: length of stay in the ICU.
Changes in model discrimination (Model 3: length of stay in the ICU)
时间窗: 30 days from hospitalization
Aim 1 Outcome: Changes in Area under receiver operating characteristic curve (AUC) \[delta AUC\] for models predicting the probability of: length of stay in the ICU.
Changes in net benefit (Model 1: need for MV in patients hospitalized with COVID-19)
时间窗: 30 days from hospitalization
Aim 1 Outcome-Changes in Net Benefit for models predicting the probability of: the need for MV in patients hospitalized with COVID-19.
Changes in model discrimination in external database after updating (Model 1: need for MV in patients hospitalized with COVID-19)
时间窗: 30 days from hospitalization
Aim 2 Outcome-Changes in Area under receiver operating characteristic curve (AUC) \[delta AUC\] for models predicting the probability of: the need for MV in patients hospitalized with COVID-19.
Changes in model discrimination in external database after updating (Model 2: mortality in patients receiving MV)
时间窗: 30 days from hospitalization
Aim 2 Outcome-Changes in Area under receiver operating characteristic curve (AUC) \[delta AUC\] for models predicting the probability of: mortality in patients receiving MV.
Changes in model calibration (Model 2: mortality in patients receiving MV)
时间窗: 30 days from hospitalization
Aim 1 Outcome-Changes in Harrell's E for models predicting the probability of: mortality in patients receiving MV.
Changes in net benefit (Model 2: mortality in patients receiving MV)
时间窗: 30 days from hospitalization
Aim 1 Outcome-Changes in Net Benefit for models predicting the probability of: mortality in patients receiving MV.
Changes in net benefit in external database after updating (Model 2: mortality in patients receiving MV)
时间窗: 30 days from hospitalization
Aim 2 Outcome-Changes in Net Benefit for models predicting the probability of: mortality in patients receiving MV.
Changes in net benefit in external database after updating (Model 3: length of stay in the ICU)
时间窗: 30 days from hospitalization
Aim 2 Outcome-Changes in Net Benefit for models predicting the probability of: length of stay in the ICU.
Changes in model calibration (Model 3: length of stay in the ICU)
时间窗: 30 days from hospitalization
Aim 1 Outcome-Changes in Harrell's E for models predicting the probability of: length of stay in the ICU.
Changes in model discrimination in external database after updating (Model 3: length of stay in the ICU)
时间窗: 30 days from hospitalization
Aim 2 Outcome-Changes in Area under receiver operating characteristic curve (AUC) \[delta AUC\] for models predicting the probability of: length of stay in the ICU.
Changes in model calibration in external database after updating (Model 1: need for MV in patients hospitalized with COVID-19)
时间窗: 30 days from hospitalization
Aim 2 Outcome-Changes in Harrell's E for models predicting the probability of: the need for MV in patients hospitalized with COVID-19.
Changes in model calibration in external database after updating (Model 2: mortality in patients receiving MV)
时间窗: 30 days from hospitalization
Aim 2 Outcome-Changes in Harrell's E for models predicting the probability of: mortality in patients receiving MV.
Changes in model calibration in external database after updating (Model 3: length of stay in the ICU)
时间窗: 30 days from hospitalization
Aim 2 Outcome-Changes in Harrell's E for models predicting the probability of: length of stay in the ICU.
Changes in net benefit in external database after updating (Model 1: need for MV in patients hospitalized with COVID-19)
时间窗: 30 days from hospitalization
Aim 2 Outcome-Changes in Net Benefit for models predicting the probability of: the need for MV in patients hospitalized with COVID-19.
次要结局
- Stakeholder perceptions, beliefs and opinions on COVID prediction models(6 months)
